EMBC
Embecta Corp
NASDAQ: EMBC · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$3.12
+6.08% today
Updated 2026-06-02
Market cap
$184.51M
P/E ratio
1.65
P/S ratio
0.18x
EPS (TTM)
$1.89
Dividend yield
19.40%
52W range
$3 – $15
Volume
2.1M
Embecta Corp (EMBC) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$3.12
12-Month target
$11.09
2030 Target
$8.81
Intrinsic (DCF)
$7.32
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: -0.09% (capped 20%) · P/E: 1.65x (capped 25x) · Margin: 10.70%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.